- Jobleads-US (New York, NY)
- …2020, further strengthened Menarini's oncology portfolio, adding both commercial and clinical - stage assets. Tagraxofusp is a novel, first in class targeted ... Radius Health to complete the development of Elacestrant, an oral SERD in late - stage Phase 3 development for hormone receptor-positive advanced breast cancer.… more
- Pfizer (New York, NY)
- …the development strategy for programs within the Late - Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for assigned ... studies maintaining current scientific and clinical knowledge in the specific therapeutic and disease area(s)... Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and… more
- Merck (Rahway, NJ)
- …human health. **Responsibilities:** This position supports statistical programming activities for late stage drug/vaccine clinical development projects. This ... tables, listings, figures), the span of which range from individual clinical trials to world-wide regulatory application submissions and post marketing support.… more
- Sanofi Group (Morristown, NJ)
- …Oncology franchise has a diverse and fast-growing portfolio. This includes the late - stage launching assets (Sarclisa(R) / isatuximab / anti-CD38) in multiple ... + Oncology background preferred + Experience / exposure to clinical development is a plus **Education Requirements:** **Required Education:** + Master's degree… more
- Merck (Rahway, NJ)
- …health. This position supports statistical programming activities for multiple and/or late stage drug/vaccine clinical development projects. Accountability ... tables, listings, figures), the span of which range from individual clinical trials to world-wide regulatory application submissions and post marketing support.… more
- Bayer (Whippany, NJ)
- …etc.); + Develop and oversee clinical trial designs (with a focus on late - stage Phase 2b to Phase 3) for radiotracer assets, in collaboration with vendors ... globally; + Ensure effective collaborations between capabilities overseeing early development stage assets (eg, Translational Sciences) and relevant late -… more
- Bristol Myers Squibb (Madison, NJ)
- …through proof of concept trials and will assure a seamless transition into late stage development (Phase II-III trials.) **Governance Participation and Signature ... and franchise aspects for potential in-licensing opportunities that shape the oncology clinical development strategy **Key Competency Requirements:** + Proven… more
- Regeneron Pharmaceuticals (Warren, NJ)
- …and execute clinical research and development studies for early and late stage assets; able to conceive and communicate strategy proposals well-grounded ... The Director Clinical Sciences, Hematology, leads in the development, evaluation,...may contribute to candidate development projects through early and late phase development. The Director reports to the Senior… more
- Sumitomo Pharma (New York, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Brooklyn, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Merck (Rahway, NJ)
- … Development PK/PD modeling and simulation stakeholders spanning both early and late - stage Oncology studies. Accountability predominantly includes the ... departmental SOPs and collaborate effectively with stakeholders (Statistician, modelers, clinical team), other functional areas and outsource partners. **Primary… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Sanofi Group (Morristown, NJ)
- …of relevant Regulatory Affairs experience (regional and global), in early and late stage , development of multiple modalities; experience within regulatory CMC ... to ensure the delivery of business objectives. This role would support our Oncology therapeutic area. We are an innovative global healthcare company with one… more
- Mitsubishi Chemical Group (New York, NY)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
